Sunitinib in hepatocellular carcinoma: redefining appropriate dosing, schedule, and activity end points.

Source:http://linkedlifedata.com/resource/pubmed/id/19901099

J. Clin. Oncol. 2009 Dec 10 27 35 e248-50; author reply e251-2

Download in:

View as

General Info

PMID
19901099